Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/04/2024
UPDATED: 11/04/2024
DUE: 10/20/2027
Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological ac...
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/04/2019
UPDATED: 10/12/2021
DUE: 10/12/2121
This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1) Co...
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/01/2023
UPDATED: 11/13/2023
DUE: 08/18/2026
Reissue of PAR-18-541. The Blueprint Neurotherapeutics Network (BPN) encourages applications from small businesses seeking support to advance their small molecule drug discovery and development projec...
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
$300,000
HHS-NIH11
POSTED: 11/01/2024
UPDATED: 11/01/2024
DUE: 10/16/2026
This announcement invites applications for basic research projects on chemical warfare agents, toxic industrial chemicals, and pesticides that have primary or secondary effects on the nervous system. ...
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
HHS-NIH11
POSTED: 05/29/2026
UPDATED: 05/29/2026
DUE: 10/25/2027
The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to support small scale research grants at institutions that do not receive substant...
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
HHS-NIH11
POSTED: 05/28/2026
UPDATED: 06/01/2026
DUE: 04/05/2029
The Commercialization Readiness Pilot (CRP) program helps small business concerns (SBCs) move NIH-funded SBIR or STTR projects from late-stage development to commercialization. The CRP supports later-...
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
HHS-NIH11
POSTED: 05/28/2026
UPDATED: 06/01/2026
DUE: 04/05/2027
The Small Business Technology Transfer (STTR) grant program helps United States small business concerns (SBCs) that partner with a nonprofit research institution bring scientific innovations to the ma...
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
HHS-NIH11
POSTED: 05/28/2026
UPDATED: 06/01/2026
DUE: 04/05/2029
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and c...
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
HHS-NIH11
POSTED: 05/28/2026
UPDATED: 06/01/2026
DUE: 04/05/2027
The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies ...
Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (SMI) (R01 Clinical Trial Optional)
$3,000,000
HHS-NIH11
POSTED: 05/28/2026
UPDATED: 05/28/2026
DUE: 10/15/2026
The purpose of this notice of funding opportunity (NOFO) is to foster research that will inform and support the optimization, delivery, sustainability, and effectiveness of empirically-supported pract...